Efficacy and safety of miniscalpel acupuncture, NSAIDs or combined treatment for chronic neck pain : an assessor-blinded randomized controlled pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002258

Enrollment

Registered

2017-03-09

Start date

2017-02-25

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug, Medical Device : This 7-week clinical trial has been designed as an assessor-blinded, randomized controlled trial with three parallel arms. Thirty-six patients will be recruited and randomly all

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) men or women aged 19-75 years 2) symptoms such as neck pain and stiffness in the neck lasting for 3 months or more 3) a baseline score of =4 on the visual analog scale (VAS) for pain 4) provision of written informed consent

Exclusion criteria

Exclusion criteria: 1) subjects with abnormalities in neurological functions such as cervical nerve function, deep tendon reflexes, and muscle and sensory functions 2) those with serious sensory or motor disorders requiring surgical treatment; 3) those with a history of spinal surgery or those with procedures scheduled during the study 4) those with spinal disorders, including vertebral fracture, spinal infection, inflammatory spondylitis, and malignancy, on computed tomography or magnetic resonance imaging 5) those who are pregnant, planning pregnancy, breast feeding, or refusing to consume certain forms of contraceptives 6) those with other chronic diseases that can affect the outcomes of the study interventions, including cardiovascular disease, diabetic neuropathy, active hepatitis, fibromyalgia, rheumatoid arthritis, dementia, and epilepsy 7) those with other severe musculoskeletal problems in areas other than the neck 8) those with serious psychiatric or psychological disorders 9) those using aspirin or anticoagulant medications 10) those with abnormal findings in blood tests for renal or hepatic function 11) those deemed ineligible by the recruiting researcher will be excluded.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale(VAS)	—

Secondary

Measure	Time frame
Neck Disability Index(NDI);EuroQol five dimensions questionnaire (EQ-5D);Patient Global Impression of Change(PGIC)	—

Countries

Korea, Republic of

Contacts

Public ContactJae-soo Kim

Daegu Haany University

jaice@daum.net+82-53-770-2108

Outcome results